Precision Health Clinical Trials

Translational Immunodiagnostics in Stroke (TrImS)

Conditions:   Acute Ischemic Stroke;   Haemorrhagic Stroke;   Transient Ischemic Attacks;   Cardioembolic Stroke;   Large-Artery Atherosclerosis (Embolus/Thrombosis);   Small Vessel Disease;   Stroke of Other Determined Etiology;   Stroke of Undetermined Etiology;   Atrial Fibrillation;   Stroke of Anterior Cerebral Artery;   Stroke of Middle Cerebral Artery;   Stroke of Basilar Artery
Intervention:   Diagnostic Test: Biomarker blood draw and saliva collection
Sponsor:   The University of Hong Kong
Recruiting

For more information, visit the Study URL.

Omics-based Predictors of NAFLD/Potential NASH

Conditions:   Non-Alcoholic Fatty Liver Disease;   Non Alcoholic Steatohepatitis
Interventions:   Diagnostic Test: Genomics (DNA Extraction);   Diagnostic Test: Epi-genomics;   Diagnostic Test: Proteomics (Glycoproteomics);   Diagnostic Test: Salivary Metabolomics;   Behavioral: Individualized counselling for behavioural modification
Sponsor:   National Research Centre, Egypt
Not yet recruiting

For more information, visit the Study URL.

Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort

Conditions:   Developmental Disability;   Intellectual Disability;   Autism Spectrum Disorder;   Congenital Anomaly;   Fragile X Syndrome;   Facioscapulohumeral Muscular Dystrophy 1
Intervention:   Other: Standard of care genetic testing group
Sponsors:   Bionano Genomics;   University of Rochester;   Columbia University;   Greenwood Genetic Center;   Praxis Genomics;   Augusta University;   Medical College of Wisconsin;   University of Iowa
Recruiting

For more information, visit the Study URL.

Prospective Study to Assess Medical Performance of Optical Mapping and Long Read Sequencing in Detecting Numerical and Structural Chromosome Abnormalities. CHROmosome MAPping and Sequencing (CHROMAPS)

Conditions:   Infertility;   Intellectual Disability;   Malformation
Interventions:   Genetic: Optical Genome Mapping (Bionano®);   Genetic: Longread sequencing (Nanopore®)
Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France
Not yet recruiting

For more information, visit the Study URL.

Effect of Genetic Polymorphisms of UGT on the PKs of Indapamide in Egyptians

Condition:   Pharmacogenomics
Intervention:   Drug: Indapamide 1.5 MG SR
Sponsor:   Ain Shams University
Not yet recruiting

For more information, visit the Study URL.

The Hong Kong Diabetes Biobank

Conditions:   Diabetes Mellitus;   Type 2 Diabetes;   Type 1 Diabetes;   Diabetic Nephropathies;   Diabetic Kidney Disease;   Diabetic Angiopathies;   Cardiovascular Diseases;   Coronary Heart Disease;   Diabetic Retinopathy;   Stroke;   Diabetes
Intervention:  
Sponsor:   Chinese University of Hong Kong
Recruiting

For more information, visit the Study URL.

Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX )

Condition:   SARS-CoV-2
Intervention:   Diagnostic Test: Enhanced Preservation Media (EPM-IX)
Sponsor:   Convergent Genomics, Inc.
Recruiting

For more information, visit the Study URL.

Prephage - Faecal Bacteriophage Transfer for Enhanced Gastrointestinal Tract Maturation in Preterm Infants - Donor Study

Conditions:   Feeding Patterns;   Microbial Colonization
Intervention:  
Sponsors:   Rigshospitalet, Denmark;   Lise Aunsholt, Neonatologist, Clinical Professor
Recruiting

For more information, visit the Study URL.

Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study

Condition:   Small Cell Lung Cancer
Intervention:   Other: Observation
Sponsors:   Tempus Labs;   AstraZeneca
Recruiting

For more information, visit the Study URL.

Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Condition:   Solid Tumors
Interventions:   Drug: Entrectinib;   Drug: Alectinib;   Drug: Atezolizumab;   Drug: Ipatasertib;   Drug: Trastuzumab emtansine;   Drug: Idasanutlin;   Drug: Inavolisib;   Drug: Belvarafenib;   Drug: Pralsetinib
Sponsor:   Hoffmann-La Roche
Recruiting

For more information, visit the Study URL.

Pages